Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-02-13 @ 11:03 AM
Study NCT ID:
NCT01163292
Status:
COMPLETED
Last Update Posted:
2018-07-06
First Post:
2010-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization: